Therapeutics Areas

The Graph shows the number of active trials within the year.

We were involved in all phases of the clinical development, from phase II to phase IV.

Our experience in this field includes:

• Alzheimer disease, Parkinson disease, depression, multiple-sclerosis, epilepsy, schizophrenia, restless leg syndrome, bipolar affective disorder, migraine, muscular dystrophy.

We can offer our experience and access to the patients with neurology / psychiatry disorders at more than 250 sites. Our presence at these highly specialized units is essential in the specific projects since it gives Pharmnet the opportunity of studying rare patient populations.

For the detailed information about the access to the populations with Neurology / Psychiatry diseases refer to Access to patients.

We were involved in all phases of the clinical development, from phase I to phase IV, recently with focus on biological treatment.

Our experience in oncology includes:

• melanoma, breast cancer, lung cancer, colorectal carcinoma, ovarian cancer, prostatic cancer , tumours of head and neck, renal cell carcinoma, AML, CML, lymphomas, cancer related pain management.

We can offer our experience and access to oncology patients at more than 60 oncology, radiology and urology departments where our staff are recently present in active trials.

For the detailed information about the access to the oncology populations refer to Access to patients.

If the feasibility survey shows insufficient recruitment potential within our region, we may offer you an access to the most of the European territory. Experience of our and partner’s staff (more than 350 employees across the Europe) is based on nearly 130 past and also recent oncology trials.

We were involved in all phases of the clinical development, from phase II to phase IV.

Our experience in cardiology includes:

• Coronary artery diseases, acute coronary syndrome, cardiogenic shock, hypertension, anticoagulation, tromboembolic events, heart failure, heart valve replacement, coronary interventions.

We can offer our experience and access to the patients with cardiac diseases at hundreds of sites from general practitioners and to specialized units of the invasive cardiology.

For the detailed information about unique health care system in cardiology and access to these patients refer to Access to patients.

Pharmnet were involved in all phases of the clinical development, from phase II to phase IV.

Our experience with metabolic diseases includes:

• Diabetes mellitus type I and II, hyperlipidemia, hypercalcemia.

We can offer our experience and access to the patients with metabolic disorder diseases at hundreds from general practitioners to specialized units at the university clinics.

For the detailed information about the access to the populations with the metabolic diseases refer to Access to patients.

Pharmnet experience with the non-interventional studies provide an extensive and reliable network of the potential investigators.

Beside extensive experience in Neurology/Psychiatry, Oncology, Cardiovascular and Metabolic diseases, we completed projects in the following areas:

• General medicine: GI polyps, ulcerous collitis, chronic hepatitis C
• Gynaecology: myomas, postmenopausal osteporosis, postmenopausis, oral contraception
• Haematology: haemophilia, thrombocytopenia
• Infectious diseases: sepsis, nosocomial infections, intrabdominal infections, influenza, respiratory infections, urinary tract infections
• Ophthalmology: glaucoma, macular degeneration, dry eyes syndrome
• Orthopaedic: ankle distortion
• Respiratory diseases: cystic fibrosis, bronchial asthma, COPD
• Rheumatology: rheumatoid arthritis, osteoarthritis
• Urology: benign prostatic hyperplasia, renal transplantation, nocturia
• Vaccination: influenza, avian flu, varicella, pneumococcus, Haemophilus B, Measles–Mumps–Rubella

For details on our experience with particular indication or area feel free to contact us.